4.7 Article

Activation of STING in the pancreatic tumor microenvironment: A novel therapeutic opportunity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

STING orchestrates the crosstalk between polyunsaturated fatty acid metabolism and inflammatory responses

Isabelle K. Vila et al.

Summary: The coordinated alteration of immune and metabolic homeostasis plays a crucial role in inflammation-related pathologies. In this study, the researchers discovered a negative regulatory feedback loop between the STING protein and the FADS2 enzyme, which fine-tunes inflammatory responses. The findings highlight the importance of metabolic alterations in human pathologies associated with abnormal STING activation.

CELL METABOLISM (2022)

Article Multidisciplinary Sciences

STING controls nociception via type I interferon signalling in sensory neurons

Christopher R. Donnelly et al.

Summary: STING is a critical immune regulator that induces type-I interferons and other cytokines to promote immune-cell-mediated clearance of pathogens and neoplastic cells. STING also plays a role in antitumour immunity and has potential as a target for cancer immunotherapy. Additionally, STING is shown to regulate nociception through IFN-I signaling, leading to pain relief in mice and non-human primates.

NATURE (2021)

Article Biochemistry & Molecular Biology

STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway

Laura Cheradame et al.

Summary: STING downregulation decreases cell survival and increases sensitivity to genotoxic treatment in breast cancer cell lines, affecting DNA Damage Response. The localization of STING at the inner nuclear membrane in breast cancer cells is independent of its partner cGAS and canonical pathway. High STING expression is associated with increased risk of relapse in breast and ovarian cancer patients receiving adjuvant chemotherapy.

ONCOGENE (2021)

Review Immunology

Nucleic Acid Immunity and DNA Damage Response: New Friends and Old Foes

Clara Taffoni et al.

Summary: The maintenance of genomic stability in multicellular organisms relies on DNA damage response (DDR), which not only repairs genomic lesions but also plays a role in inflammatory responses. The crosstalk between pattern recognition receptors (PRRs) and DDR proteins influences innate immune activation, potentially impacting pathological outcomes. Understanding the molecular determinants of this cooperation will be crucial for future therapeutic approaches.

FRONTIERS IN IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies

Marwa Elsayed et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is currently the fourth leading cause of cancer deaths in the US, with projections to become the second leading cause by 2030. The lack of effective early screening tests, undetectable micro-metastasis at presentation, low mutation burden, immunological profile, dense tumor stroma, and decreased tumor sensitivity to drugs all contribute to the low survival rates in PDAC patients. Researchers must focus on understanding PDAC pathology and immunological behavior, and utilize advanced screening modalities and new therapeutic agents for improved outcomes.

BIOMEDICINES (2021)

Article Biology

Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors

Amanda Rosewell Shaw et al.

Summary: The combination therapy of CAdTrio and HER2.CART shows promising results in eradicating metastatic PDAC, with curative responses observed in PDAC xenografts and humanized mouse models. This cooperative therapy has the potential to be effective in treating PDAC patients.

COMMUNICATIONS BIOLOGY (2021)

Article Oncology

Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity

Colin Hutton et al.

Summary: This study used mass cytometry to analyze the stromal composition in murine tissues and tumors, revealing extensive stromal heterogeneity and coordinated relationships between mesenchymal and immune cell subsets in pancreatic ductal adenocarcinoma. The research identified two stable and functionally distinct pancreatic fibroblast lineages marked by CD105 expression, with CD105-positive fibroblasts promoting tumor growth and CD105-negative fibroblasts suppressing tumors, dependent on adaptive immunity. These findings highlight the importance of mesenchymal and immune cell interactions in restricting tumor growth.

CANCER CELL (2021)

Article Biology

Drosophila STING protein has a role in lipid metabolism

Katarina Akhmetova et al.

Summary: STING plays an important role in lipid metabolism in Drosophila, with the deletion of STING leading to increased sensitivity to starvation and oxidative stress, reduced lipid storage, and downregulated expression of lipid metabolism genes. STING interacts with lipid synthesizing enzymes ACC and FASN, and their deletion results in disturbed ACC localization and decreased FASN enzyme activity. This study reveals a previously unknown role of STING in lipid metabolism in Drosophila.
Article Oncology

High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege

Casey R. Ager et al.

Summary: This study demonstrates that high-potency STING agonists can repolarize suppressive myeloid populations and enhance sensitivity of pancreatic adenocarcinoma to immune checkpoint blockade therapy. The findings provide insights into the unique pathways engaged by CDNs in functional repolarization.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation

Takashi Nakamura et al.

Summary: STING-LNP treatment can overcome PD-1 resistance by activating NK cells, resulting in an increase in PD-L1 expression on cancer cells and ultimately producing a synergistic antitumor effect.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Review Oncology

STING Agonists as Cancer Therapeutics

Afsaneh Amouzegar et al.

Summary: Immunotherapies have significantly impacted cancer treatment, yet some patients do not respond effectively. Recent efforts have been focused on identifying targets that could enhance anti-tumor immune responses, with STING pathway being one novel and promising target. Research on STING agonists has opened avenues for developing more effective strategies in cancer immunotherapy.

CANCERS (2021)

Article Oncology

Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment

Erin Helms et al.

Cancer Discovery (2020)

Article Multidisciplinary Sciences

Lysyl-tRNA synthetase produces diadenosine tetraphosphate to curb STING-dependent inflammation

J. Guerra et al.

SCIENCE ADVANCES (2020)

Review Gastroenterology & Hepatology

Pancreatic cancer stroma: an update on therapeutic targeting strategies

Abdel N. Hosein et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Immunology

NK cells mediate clearance of CD8(+) T cell-resistant tumors in response to STING agonists

Christopher J. Nicolai et al.

SCIENCE IMMUNOLOGY (2020)

Review Medicine, General & Internal

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy

Leila Motedayen Aval et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Medicine, Research & Experimental

Development of small molecule inhibitors/agonists targeting STING for disease

Kaifeng Liu et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Medicine, Research & Experimental

PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer

Roman M. Chabanon et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Gastroenterology & Hepatology

Molecular subtypes of pancreatic cancer

Eric A. Collisson et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Medicine, Research & Experimental

STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade

Hannah Yang et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Medicine, Research & Experimental

STING activation in cancer immunotherapy

Ting Su et al.

THERANOSTICS (2019)

Article Engineering, Biomedical

STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy.

David G. Leach et al.

BIOMATERIALS (2018)

Review Biotechnology & Applied Microbiology

Myeloid-derived suppressor cells and their role in pancreatic cancer

M. Pergamo et al.

CANCER GENE THERAPY (2017)

Article Medicine, Research & Experimental

PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy

Abul Azad et al.

EMBO MOLECULAR MEDICINE (2017)

Article Immunology

The Common R71H-G230A-R293Q Human TMEM173 Is a Null Allele

Seema Patel et al.

JOURNAL OF IMMUNOLOGY (2017)

Article Medicine, Research & Experimental

Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors

Tyrel T. Smith et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Immunology

Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes

Silvia Cerboni et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Article Immunology

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Daniel Ohlund et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Article Multidisciplinary Sciences

DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway

Juli Bai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Multidisciplinary Sciences

Host STING-dependent MDSC mobilization drives extrinsic radiation resistance

Hua Liang et al.

NATURE COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

Signalling strength determines proapoptotic functions of STING

Muhammet F. Gulen et al.

NATURE COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer

Julienne L. Carstens et al.

NATURE COMMUNICATIONS (2017)

Review Immunology

Type I Interferons and Natural Killer Cell Regulation in Cancer

Lena Mueller et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Oncology

The Pancreatic Cancer Microenvironment

Stephanie K. Dougan

CANCER JOURNAL (2017)

Article Oncology

Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma

Giovanni Francesco Castino et al.

ONCOIMMUNOLOGY (2016)

Article Oncology

Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells

Chih-Hang Anthony Tang et al.

CANCER RESEARCH (2016)

Article Gastroenterology & Hepatology

Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection

Martin K. Thomsen et al.

HEPATOLOGY (2016)

Article Multidisciplinary Sciences

Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer

Qing Chen et al.

NATURE (2016)

Review Oncology

The biology and function of fibroblasts in cancer

Raghu Kalluri

NATURE REVIEWS CANCER (2016)

Article Chemistry, Multidisciplinary

Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma

Takashi Nakamura et al.

JOURNAL OF CONTROLLED RELEASE (2015)

Article Multidisciplinary Sciences

STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity

Olivier Demaria et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Biochemistry & Molecular Biology

Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs

Lingyin Li et al.

NATURE CHEMICAL BIOLOGY (2014)

Article Multidisciplinary Sciences

Inflammation-driven carcinogenesis is mediated through STING

Jeonghyun Ahn et al.

NATURE COMMUNICATIONS (2014)

Article Medicine, Research & Experimental

DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGFR2 in particular

Christina M. Buchanan et al.

CLINICAL SCIENCE (2012)

Review Biochemistry & Molecular Biology

Lipid metabolism in cancer

Claudio R. Santos et al.

FEBS JOURNAL (2012)

Article Multidisciplinary Sciences

STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity

Hiroki Ishikawa et al.

NATURE (2009)

Article Immunology

Type I IFN contributes to NK cell homeostasis, activation, and antitumor function

Jeremy B. Swann et al.

JOURNAL OF IMMUNOLOGY (2007)

Article Immunology

IFN-α/β enhances BCR-dependent B cell responses

D Braun et al.

INTERNATIONAL IMMUNOLOGY (2002)